Novogenia AG Company Description

Novogenia AG manufactures and sells personalized health products in global markets.

The company offers products, such as personalized supplements and cosmetics; and services, including genetic testing, advanced therapies like personalized infusion therapies and reproductive genetics, and contract manufacturing.

The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany.

Novogenia AG

Country	Germany
Founded	2021
Industry	Biological Products, Except Diagnostic Substances
Employees	204
CEO	Daniel Wallerstorfer

Contact Details

Address: Brienner Strasse 7 Munich, 80333 Germany
Phone	49 20 500 450
Website	novogenia.com

Stock Details

Ticker Symbol	7V0
Exchange	Munich Stock Exchange
Fiscal Year	January - December
Reporting Currency	EUR
SIC Code	2836

Key Executives

Name	Position
Daniel Wallerstorfer	Chief Executive Officer